A range of authors across academia and industry, representing both the VPHi and the Avicenna Alliance, have produced a new white paper on potential of the use of computer modelling and simulation in healthcare, with a particular focus on the role of Artificial Intelligence, that is intended to stimulate policy making, regulatory thinking and research strategies in this exciting space.
The past decade has produced overwhelming evidence that changes in the health status of individuals, measured by well-defined clinical endpoints utilizing novel digital biomarkers, can in many cases offer predictive and prescriptive capabilities. This use of computer modelling and simulation in healthcare is generally referred to as “in silico medicine”. This white paper aims to provide clarity on the overlap and synergies between the different in silico medicine approaches, including AI.
Using the generalized terms of "knowledge-driven models" and "data-driven models", this new paper offers a number of policy recommendations in making it clear that all healthcare stakeholders are required to participate in advancing in silico technologies.
It is recognized that AI methods – as other in silico medicine technologies - are incredibly powerful and with a future focused on balanced regulation and intensive research these methods can realize enormous potential in the global provision of healthcare.
Read the full paper
